InsiderStreet Equity Research

Produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation for any investor. Do not rely on it for any investment decision.

Last Close

$317.95

2026-10-16

Market Cap

$25.8B

Volume

0.7M

52-Wk High

$341.80

52-Wk Low

$244.52

Trailing PE

26.1

P/S

1.80

Gross Margin

27.8%

Net Margin

7.0%

ROE

12%

ROIC

8%

Piotroski

8/9

Altman Z

3.4

1-Yr Return

+13.2%

5-Yr Return

+133.7%

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

SectorHealthcareIndustryMedical - Diagnostics & ResearchExchangeNYSEMarket Cap$25.8BEmployees71,000 (SEC-filed)CEOAdam H. SchechterIPO1990-03-29CountryUS

358 South Main Street, Burlington, NC 27215 · Tel 336 229 1127 · labcorp.com

INSIDERSTREET SCORE62 / 100Street mean $343.25 (8 analysts, last qtr) — their number, not ours

INSIDER CONSENSUS SIGNALROUTINE SELLING — LOW SIGNAL$8M sold / 6 mo, zero open-market buys

INSIDERSTREET
SCORE62of 100

Score Breakdown

Profitability	37/100
Growth	62/100
Momentum	89/100
Quality	73/100
Earnings Quality	76/100
Balance Sheet	50/100
Value	53/100
Risk (safety)	80/100
Overall	62.1/100

Each component is a diagnostic reading on its own 0-100 scale. The overall score is computed separately from the underlying financials and is not the average of the rows above — components are not equally weighted and three of them (Momentum, Value, Risk) are derived partly from price rather than from the business.

Peer Comparison — IS Score

Symbol	IS Score
DGX	62
GH	42
MTD	63
EXAS	50
MEDP	84
RVTY	50
LH	62

IS Score Trend — quarterly

14 quarters, 23 Q1 to 26 Q2. Peak 66 in 25 Q3, latest 62 — -4 since. Fell in 2 of the last 4 quarters. Dashed line marks 40 on the 0-100 scale.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

1 Year vs S&P 500 · LH +13.2% · S&P 500 +15.9% · spread -2.7pp

7 Years vs S&P 500 · LH +133.7% · S&P 500 +189.9% · spread -56.1pp

Both charts indexed to 100 at the start of their window and drawn on a single shared scale, so the gap to the benchmark is the gap you see. Adjusted closes throughout.

BUSINESS QUALITY62 / 100IS Score 62.1 / 100 · -3.7 from peak of 66

Fundamental factor model, quarterly. Measures how the business is doing - not where the price is going.

PRICE STRUCTUREBULLISHTechnical Score 70 / 100 · Power +41 · 17 of 22 indicator votes bullish

Vote share across trend, momentum, volume, volatility and pattern families. Describes where the price is, not where it is going.

Both readings sit above the midpoint — business quality at 62 and price structure at 70 out of 100 — so they are not in conflict. The fundamentals and the tape are saying the same thing, which is the case in which either one alone would have been enough.

Trigger	Where it stands now	What it would mean
IS Score reaches 75 and holds two consecutive quarters	now 62.1	would move us up one band
IS Score stops falling - one quarter higher than the prior	last four: 66 → 61 → 64 → 62	the direction matters more than the level
Technical vote share back above 50%	now 82%	price structure no longer broken
Institutional holder count rises two quarters running	peak 1,051 → now 1,051	fewer institutions willing to hold is our clearest warning

We publish these so the view can be shown to be wrong. If none of them move and our reading does, we owe you an explanation.

This page is InsiderStreet's own reading, produced from the data in the rest of this document. It is not a price target and not investment advice. Analyst consensus and street price targets appear later under their own heading and are the street's numbers, not ours.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Site Convergence Score3 of 4top 4% of 29,420 symbols

Sources Aligned— of 3independent disclosures

Congress (180d)2 buys2026-09-04

Insider Buys (180d)0none disclosed

ETF Funds (30d)949 up / 909 downnet +40 funds

Institutions Added (13F)27managers opening or increasing

Congressional and insider figures are disclosed purchases in the trailing 180 days; ETF figures are COUNTS OF FUNDS whose holding changed in 30 days, not dollars. Coincidence of separate disclosures, not coordination. An absent source means nothing qualifying was disclosed in its window.

Institutions holding — 12 quarters

Peak 1,051 · latest 1,051 (+0 from peak).

Quarter	Holders	13F shares	Value	Reported own%
2026 Q2	1,051	80.0M	$21.8B	97.9%
2026 Q1	1,024	78.2M	$20.3B	95.7%
2025 Q4	1,018	80.1M	$19.7B	98.0%
2025 Q3	995	77.4M	$22.0B	94.8%
2025 Q2	963	80.4M	$20.7B	98.4%
2025 Q1	967	78.2M	$18.0B	95.7%
2024 Q4	914	78.2M	$17.7B	95.8%
2024 Q3	909	76.6M	$16.8B	93.7%
2024 Q2	816	76.8M	$15.6B	94.1%
2024 Q1	3	0.0M	$0.0B	0.0%
2023 Q4	5	0.0M	$0.0B	0.0%
2023 Q3	3	0.0M	$0.0B	0.0%

How to read ownership above 100%. A 13F reports the positions a manager has investment discretion over, and where two or more managers share discretion over the same block, each one reports it. Summed across filers, the total can therefore exceed the shares actually outstanding without anything being wrong. We publish the figure as filed rather than netting it down, and flag separately any quarter where the arithmetic is not merely high but impossible.

Insider	Role	Date	Type	Shares	Value	Post-Txn Owned
Caveney Brian J	EVP, Pres of BLS, CMO & CSO	2026-09-01	A-Award	3,000	—	7,170
Oyegunwa Akinbolade	EVP, CIO & CTO	2026-09-01	A-Award	750	—	2,940
Meltzer Jonathan C	EVP, COO	2026-09-01	A-Award	900	—	3,594
Vaughn Bryan T	EVP and President, Diagnostics	2026-09-01	A-Award	1,500	—	5,204
Anderson Kerrii B	director	2026-08-17	SELL	3,000	$0.95M	6,563
Schechter Adam H	director, President & CEO	2026-08-11	SELL	4,669	$1.50M	102,565
Summy Amy B.	EVP, Chief Marketing Officer	2026-08-04	SELL	924	$0.28M	6,956
Wilkinson Peter J	SVP, Chief Accounting Officer	2026-08-03	SELL	82	$0.03M	1,770

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

6-mo decomposition (Form 4)	Txns	Shares	Value	Signal weight
S — Open-market sales	13	28,729	$8.2M	Counted
M — Exercises (paired A/D)	3	1,921	$0.3M	None — mechanics
F — Tax withholding	16	47,913	$12.9M	None — compensation
P — Open-market purchases	0	0	$0	Counted — none occurred

Monthly Net Insider Flow (000 shares)

Net of acquisitions minus dispositions, all Form 4 types.

Signal Summary

SignalRoutine Selling — Low Signal

Open-Market Sells$8.2M13 txns / 6 mo

Open-Market Buys$0.0M0 txns / 6 mo

ClusterNone active3+ insiders / 21 days

Filed	Filer	Shares registered	Est. proceeds
2026-08-11	Schechter Adam H	4,669	$1.5M
2026-08-04	Summy Amy B.	924	$0.3M
2026-07-02	Vaughn Bryan T	234	$0.1M
2026-07-02	Kyle Kathryn W	92	$0.0M
Trailing 12 mo	17 filings	49,942	$14M

Filed	Form	Reporting person	% of class	Shares
2026-04-28	SCHEDULE 13G	Vanguard Capital Management	7.52%	6.2M sh
2026-03-26	SCHEDULE 13G/A	The Vanguard Group	—	exit/reporting change
2025-04-24	SCHEDULE 13G/A	BlackRock, Inc.	7.60%	6.3M sh

Member	Chamber	Trade	Size band	Traded	Disclosed
Ro Khanna	House	BUY	$1,001 - $15,000	2026-09-04	2026-10-09
April Delaney	House	SELL	$100,001 - $250,000	2026-08-25	2026-09-10
April McClain Delaney	House	SELL	$100,001 - $250,000	2026-08-25	2026-09-10
Alan Armstrong	Senate	BUY	$1,001 - $15,000	2026-03-27	2026-07-20
Dan Sullivan	Senate	SELL	$1,001 - $15,000	2023-08-22	2023-09-22
Dan Sullivan	Senate	SELL	$1,001 - $15,000	2023-08-22	2023-09-21

House 12-Mo30 trades17 purchases

Senate 12-Mo1 trades1 purchases

CoverageSTOCK Act filings30-45 day disclosure lag

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

13F Filers (last complete Q)1,024

13F Shares78M95.7% of shares out

New / Closed107 / 86positions, QoQ

Increased / Reduced334 / 377positions, QoQ

Put/Call (13F)0.82option positions

Free Float99.6%81M sh

2.8 · Largest Reporting 13F Managers

Manager	Shares	Value
Mcrae Capital Management Inc	77,924	$24M
Wealth Enhancement Advisory Servic	57,778	$8M
American National Bank & Trust	46,038	$14M
Equitable Trust Co	40,188	$12M
Birch Hill Investment Advisors Llc	37,629	$12M
Wealthbridge Investment Counsel In	34,421	$11M

EDGAR 13F holdings as of 2026-09-30; filer values normalized to dollars.

2.9 · Top ETF & Fund Ownership

Fund	Weight	Position
VITSX	0.0%	$793M
VTI	0.0%	$793M
VSMPX	0.0%	$793M
VTSAX	0.0%	$793M
VFFSX	0.0%	$656M
VOO	0.0%	$656M

13F Filers Holding LH — quarterly

Institutional Put/Call — quarterly

Daily short-sale volume as % of volume reported in FINRA's short-sale file — a flow measure, not short interest; dashed = 50-day average.

Latest Session55.4%2026-10-15

20-Day Avg46.7%50-day 52.7%

TrendFalling20d vs 50d

By Market CenterQ: 55% · N: 71% · B: 76%latest session

Weekly Notional ($B)

Where LH Trades in the Dark

ATS Venue (4-wk)	Shares	Avg trade
Ubsa Ubs Ats	0.8M	24 sh
Ebxl Level Ats	0.5M	16 sh
Sgmt Sigma X2	0.5M	18 sh
Mlix Instinct X	0.4M	32 sh
Incr Intelligent Cross Llc	0.4M	25 sh
Mstx Ms Trajectory Cross (Ats-1)	0.4M	17 sh

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Where a dollar of Labcorp Holdings Inc. revenue goes. All values FY2025 filings, live.

LH (live moat model)Peer median: DGX · GH · MTD · EXAS · MEDP

Component scores from the live moat model. Peer median illustrative.

Moat score 42/100 — Weak; primary source Efficient Scale.

3.8 · Employees (SEC filings)

Officer	Title
Adam H. Schechter	President, Chief Executive Officer & Chairman
Julia Wang	Chief Financial Officer & Executive Vice President
Anita Z. Graham	Executive Vice President & Chief Human Resources Officer
Brian J. Caveney	Exec VP, President of Biopharma Laboratory Services & Chief Medical and Scientific Officer

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Revenue ($B)

EPS ($) — GAAP diluted actual, street-basis estimate

Actual bars are GAAP diluted EPS from the filed income statement; the lighter forward bars are street-basis consensus. The two are different measures and are not comparable quarter to quarter.

Quarterly EPS — Actual vs. Consensus

Beats (>2%)5 of 6recent quarters

Avg Surprise+3.2%

Next Report2026-10-28

Income Quality1.63OCF ÷ net income

Beat Rate—%0 of 0 quarters

Current Streak0longest 0

Avg EPS Surprise—%median —%

Surprise Trend—last 4 vs prior 4

Period	EPS est.	EPS actual	EPS surprise	Rev est. ($M)	Rev actual ($M)	Rev surprise

Announcement dates to . Consensus as it stood at each report. Revenue surprise shown where both estimate and actual are filed. A beat record is history, not a forecast.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Profit Margins (%)

Revenue by Segment — Stacked

Live segmentation data.

YoY Growth Heatmap — Income Lines

YoY growth	FY21	FY22	FY23	FY24	FY25
Revenue	-6.0%	-9.7%	+2.5%	+7.0%	+7.2%
Gross profit	+0.8%	-25.7%	-9.3%	+7.7%	+3.0%
Operating income	+24.7%	-52.9%	-49.5%	+49.8%	+39.5%
Net income	+52.8%	-46.2%	-67.3%	+78.5%	+17.5%

$B · FY ends	FY21	FY22	FY23	FY24	FY25
Revenue	13.1	11.9	12.2	13.0	14.0
Cost of revenue	8.1	8.2	8.8	9.4	10.2
Gross profit	5.0	3.7	3.4	3.6	3.7
R&D expense	0.0	0.0	0.0	0.0	0.0
SG&A expense	1.7	2.0	2.0	2.2	2.2
Operating income	3.0	1.4	0.7	1.1	1.5
EBITDA	3.7	2.0	1.3	1.8	2.0
D&A	0.6	0.5	0.6	0.6	0.7
Pretax income	2.9	1.2	0.6	1.0	1.1
Income tax	0.7	0.2	0.2	0.2	0.2
Net income	2.4	1.3	0.4	0.7	0.9
Diluted EPS ($)	24.38	13.96	4.77	8.84	10.46
Diluted shares (M)	98	92	88	84	84

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Operating CF$2B

CapEx$0B

Free cash flow$1B

SBC$0B

Buybacks$0B

Net cash change$-1B

Balance Sheet — Full

$B	FY22	FY23	FY24	FY25
Cash & equivalents	0.3	0.5	1.5	0.5
ST investments	0.0	0.0	0.0	0.0
Receivables (net)	2.0	2.1	2.1	2.3
Total current assets	4.6	3.8	4.8	4.0
PP&E (net)	2.8	2.9	3.0	3.1
Goodwill + intangibles	9.2	9.5	9.9	10.4
Total assets	20.2	16.7	18.4	18.4
Accounts payable	0.9	0.8	0.9	0.8
Short-term debt	0.3	1.0	1.0	0.7
Deferred revenue	0.3	0.4	0.4	0.4
Total current liabilities	3.1	3.2	3.3	2.8
Long-term debt	5.0	4.1	5.3	5.8
Total liabilities	10.0	8.8	10.3	9.8
Shareholders' equity	10.1	7.9	8.1	8.6

Cash Flow Statement — Full

$B	FY22	FY23	FY24	FY25
Net income	1.0	0.4	0.7	0.9
D&A	0.5	0.6	0.6	0.7
Stock-based compensation	0.1	0.1	0.1	0.1
Working capital change	(0.6)	(0.4)	(0.2)	(0.5)
Operating cash flow	2.0	1.3	1.6	1.6
Capital expenditures	(0.5)	(0.5)	(0.5)	(0.4)
Investing cash flow	(1.7)	(1.2)	(1.4)	(1.2)
Buybacks	(1.2)	(1.0)	(0.3)	(0.5)
Dividends paid	(0.2)	(0.3)	(0.2)	(0.2)
Debt issuance / (repay)	0.0	(0.3)	1.0	(0.8)
Financing cash flow	(1.3)	(0.1)	0.8	(1.5)
Free cash flow	1.5	0.9	1.1	1.2

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Balance Sheet Structure ($B)

Cash Generation vs Capex ($B)

Left: what the balance sheet is made of — the gap between the assets bar and the liabilities bar is book equity. Right: whether the capex bar is covered by the operating-cash bar; where it is not, the difference was funded externally and free cash flow goes negative.

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
PROFITABILITY
ROE	24.1%	12.6%	4.7%	9.4%	10.5%	12%
ROA	11.8%	6.3%	2.3%	4.3%	4.8%	5.4%
ROIC	16.4%	8.1%	3.7%	6.1%	7.8%	7.9%
Gross margin	38.0%	31.3%	27.7%	27.9%	26.8%	27.8%
Operating margin	23.2%	12.1%	6.0%	8.4%	10.9%	11.3%
Net margin	18.1%	10.8%	3.4%	5.7%	6.3%	7.0%
EBITDA margin	28.0%	16.5%	11.1%	13.9%	14.4%	15.0%
FCF margin	16.4%	11.0%	7.0%	8.4%	8.6%	—
VALUATION
P/E	10.43	13.56	45.07	25.60	23.81	26.1
P/B	2.41	1.72	2.39	2.37	2.42	3.0
P/S	1.54	1.30	1.55	1.47	1.50	1.80
P/FCF	9.36	11.77	22.21	17.43	17.31	22.3
EV/EBITDA	6.94	10.81	14.70	13.72	13.69	15.1
EV/Revenue	1.84	1.74	1.99	1.91	1.97	2.3
Earnings yield	9.6%	7.4%	2.2%	3.9%	4.2%	3.86%
FCF yield	10.7%	8.5%	4.5%	5.7%	5.8%	4.48%

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
LEVERAGE & SOLVENCY
Current ratio	1.92	1.50	1.17	1.44	1.42	1.80
Quick ratio	1.77	1.35	1.02	1.30	1.23	1.53
Debt / equity	0.62	0.62	0.76	0.90	0.84	0.79
Debt / assets	31.1%	31.0%	35.6%	39.6%	39.2%	36.5%
Net debt / EBITDA	1.14	2.75	3.28	3.18	3.31	3.08
Interest coverage	15.74	8.54	5.44	5.61	5.94	—

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
EFFICIENCY
Asset turnover	0.80	0.66	0.66	0.74	0.76	0.77
Receivables turnover	6.80	6.60	6.58	6.74	6.64	5.7
DSO (days)	54	55	56	54	55	64
DPO (days)	22	29	35	33	31	24
Cash conversion cycle	46	44	40	40	42	59
GROWTH (YoY)
Revenue growth	15.3%	-17.1%	-9.0%	7.0%	7.2%	—
Net income growth	52.8%	-46.2%	-67.3%	78.5%	17.5%	—
EPS growth	56.1%	-41.8%	-65.7%	80.0%	18.9%	—
FCF growth	51.1%	-44.4%	-42.5%	29.2%	10.0%	—
PER SHARE ($)
EPS (diluted, TTM)	24.71	14.37	4.92	8.86	10.53	12.27
Book value / share	106.79	113.44	92.76	95.63	103.60	105.55
Revenue / share	167.58	150.15	143.25	154.50	167.69	175.62
FCF / share	27.54	16.56	9.99	13.02	14.50	14.14
Cash / share	15.31	3.60	6.32	18.04	6.40	1.74
SHAREHOLDER RETURN & SCORES
Buyback yield	6.8%	6.4%	5.3%	1.3%	2.2%	3.06%
Altman Z-Score	3.67	2.78	2.92	2.76	3.02	3.4
Piotroski F-Score	8	5	5	7	7	8/9
Beneish M-Score	-2.54	-2.81	-2.77	-2.68	-2.54	-2.52

Model	Score	Zone	Note
Piotroski F-Score	8 / 9	Strong
Altman Z-Score	3.4	Safe (>2.99)	Safe
Income quality	1.63	Cash-backed	OCF ÷ net income
Beneish M-Score	-2.52	Non-manipulator	vs −2.22 threshold

DuPont Decomposition (TTM)	Value
Tax burden	0.81
Interest burden	0.85
Operating margin	10.1%
Asset turnover	0.78×
Financial leverage	2.14×
= ROE	12%

Growth Quality (live)	Value
Revenue stability	0.22
Earnings stability	0.60
Earnings persistence	0.87
Revenue CAGR 3y	4.4%
EPS CAGR 3y	9.4%
FCF CAGR 3y	2.6%

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Buyback Yield3.06%

Dividend Yield0.91%

Total Shareholder Return3.82%cash yield

SBC / Revenue0.9%dilution pressure

Company	Mkt cap	P/E	ROE	Net margin	Rev growth	Piotroski	1-yr ret
DGX	$25.9B	24.6	14%	10.5%	+9.9%	8/9	+25.8%
GH	$21.3B	-45.4	172%	-35.9%	+42.7%	6/9	+135.1%
MTD	$32.5B	36.4	-736%	22.7%	+6.9%	8/9	+19.2%
EXAS	$20.0B	-188.6	-9%	-9.8%	+17.7%	7/9	+119.7%
MEDP	$17.3B	35.6	162%	17.2%	+24.7%	8/9	—
RVTY	$17.0B	72.7	3%	7.1%	+5.5%	6/9	—
ILMN	$39.6B	48.5	32%	17.9%	+4.9%	7/9	—
WAT	$42.9B	108.7	2%	-8.3%	+52.5%	5/9	—

1-yr returns computed from adjusted price history; peers without a tracked series show —.

Buy

35 Analysts

Str Sell (0)Sell (0)Hold (9)Buy (26)Str Buy (0)

Mean Target (qtr)$343.258 targets

Target vs. Price+8.0%last-quarter mean

Next Report2026-10-28street $4.65

Consensus estimates	Revenue mean	High / Low	EPS mean	High / Low	# EPS est.
FY2026	$14.75B	$14.80B / $14.71B	$18.35	$18.46 / $18.13	10
FY2027	$15.47B	$15.69B / $15.27B	$19.83	$20.26 / $18.87	12
FY2028	$16.24B	$16.29B / $16.19B	$21.60	$24.45 / $19.42	8

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Street Price Target — Trajectory

Window	Avg Target	vs. Price	# Targets
Last Month	$365.00	+14.8%	1
Last Quarter	$343.25	+8.0%	8
Last Year	$330.31	+3.9%	16
All Time	$308.61	-2.9%	41

Rolling mean of published targets vs. last close $317.95. Aggregated from StreetInsider, Benzinga, Pulse 2.0.

Third-Party Composite Rating

B+

DCF

4/5

ROE

4/5

ROA

4/5

Debt/Eq

1/5

P/E

2/5

P/B

3/5

Independent quant composite as of 2026-10-16; components scored 1–5 (5 best). Shown for contrast with the InsiderStreet Score — methodologies differ.

LH +13.2% vs S&P 500 +15.9% — spread -2.7pp

Sector — XLV +24.2%

Peer Set — indexed to 100

All series indexed to 100 at the start of the window, adjusted closes.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Candlesticks with SMA 20/50 overlay, Bollinger (20,2σ) band, volume, and Wilder RSI(14) — computed from live daily OHLCV.

Moving Average	Value	Distance	% Distance	Signal
SMA 20	$312.14	+5.81	+1.86%	Above
SMA 50	$320.22	-2.27	-0.71%	Below
SMA 200	$282.39	+35.56	+12.59%	Above
EMA 9	$316.20	+1.75	+0.55%	Above
EMA 21	$315.10	+2.85	+0.90%	Above
EMA 50	$312.70	+5.25	+1.68%	Above
EMA 200	$288.67	+29.28	+10.14%	Above

Series and readings from the nightly technical-indicator history — identical data to the site's ribbon chart. Supertrend segments colored by direction.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

TECHNICAL VERDICTBULLISHPower Score +4117 of 22 indicator votes bullish

Family Scores (site weights)

Trend 30%67

Momentum 25%91

Volume 20%69

Volatility 10%83

Patterns 15%38

This Week82% bullishof 11 price-based votes

4 Weeks Ago27%+55 pts since

12 Weeks Ago100%-18 pts since

ReadImprovingweek-over-week trajectory

Price vs SMA 20$312.14

Price vs SMA 50$320.22

Price vs SMA 200$282.39

EMA 9/21 Cross316.2/315.1

SMA 50/200Golden

ADX DirectionADX 14

Supertrend$327

Parabolic SAR$307

SMA Slope-0.140

RSI53.1

Stochastic K/D82/81

StochRSI K/D88/92

Williams %R-39

CCI134

TSI vs Signal0.9

CMO6.2

ROC3.07%

OBV SignalAccum

Chaikin MF0.060

MFI78

Force Index-0M

Elder Ray Bull12.40

RSI (14)30 oversold · 70 overbought

Stochastic %Kvs %D 81

Money Flowvolume-weighted RSI

ADXtrend strength · <20 weak

Williams %Rinverted scale

Level	Value	Level	Value
Pivot / R1 / R2	$323.48 / $326.74 / $328.41	S1 / S2	$321.81 / $318.55
Bollinger (20,2)	$301.91 – $322.38	Squeeze	ON
52-wk range	$242.07 – $341.07	Off 52-wk high	-6.8%
ATR (14)	$7.14 (2.2%)	Historical vol	21.8%

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

+1.7%Jan65%

+1.3%Feb55%

-0.9%Mar67%

+2.9%Apr60%

+0.8%May60%

+2.5%Jun70%

+0.8%Jul45%

-0.6%Aug45%

-1.2%Sep45%

+0.4%Oct65%

+2.3%Nov75%

+0.4%Dec60%

Sample: 20 years — treat short histories as suggestive, not statistical.

Computed from live weekly prices	LH	S&P 500
Weekly volatility (σ, 1y)	3.98%	1.83%
Best / worst week (1y)	+9.1% / -11.2%	—
Max drawdown (5y, monthly)	-43.2%	—
1-week VaR (95%)	-5.8%	—
Beta (5y)	0.85	1.00

LH EQUITY WEATHER (LIVE)CLOUDY · +1

Trend-20

Momentum+31

Volume+35

Volatility-30

Breadth-30

MARKET REGIME (2026-10-16)NEUTRAL

VIX19.99Normal

Dow TheoryConfirmed Bearish

SPY / QQQ TSI7.2 / 4.7trend strength

Sector Strength46/100breadth average

Average sentiment of 172 stories, weekly buckets, −1 to +1.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Overall+1.5+18.5 vs industry

Trend-19.6-12.3 vs industry

Momentum+31.4+58.3 vs industry

Volume+35.2+35.2 vs industry

Reading	LH	Medical - Diagnostics & Research n=227	Healthcare n=5,272	All US symbols n=70,435
Overall	+1.5	-17.0	-24.0	-20.5
Trend	-19.6	-7.2	-25.6	-21.3
Momentum	+31.4	-27.0	-28.5	-15.8
Volume	+35.2	+0.0	-25.0	-3.8

Trend, momentum and volume are computed per company. Volatility and breadth are market-regime values shared by every symbol in the universe, so they are reported once under Market Regime rather than compared here - a company cannot differ from its sector on a constant.

Executive	Total comp	Structure
ADAM H. SCHECHTER President and Chief Execut	$18.3M	73% equity+incentive
JULIA A. WANG Executive Vice President and C	$5.0M	68% equity+incentive
MARK S. SCHROEDER Former Executive Vice Pres	$4.8M	68% equity+incentive
BRIAN J. CAVENEY Executive Vice President an	$4.4M	69% equity+incentive
MEGAN D. BAILEY Executive Vice President and	$2.7M	66% equity+incentive

Pillar (live disclosure scores)	Score
Environmental	52
Social	50
Governance	58
Composite ESG	53

Composite ESG Trend

Filed	8-K contents	Items
2026-09-30	Regulation FD; Exhibits	7.01,9.01
2026-09-22	Regulation FD	7.01
2026-09-10	Regulation FD; Exhibits	7.01,9.01
2026-08-28	Regulation FD; Exhibits	7.01,9.01
2026-08-17	Regulation FD; Exhibits	7.01,9.01
2026-08-14	Officer/Director Change	5.02
2026-07-30	Earnings Release; Exhibits	2.02,9.01
2026-07-10	Regulation FD; Exhibits	7.01,9.01

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Methodology. Every figure originates in InsiderStreet's production data layer and is computed deterministically by the same engines that power insiderstreet.ai. This factsheet contains no model-written text. Sections without underlying data are omitted rather than estimated.

DISCLOSURES. This document is produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation tailored to any person. Data is sourced as of the dates shown and may no longer be current. InsiderStreet.ai is not a registered investment adviser or broker-dealer. Investing involves risk, including loss of principal. Past performance does not guarantee future results. Do not make any investment decision based on this document. © 2026 InsiderStreet.ai — all rights reserved. Redistribution prohibited.

Data domain	Source	Coverage for this report
Price & volume	market_db.historical_prices	52 rows
Fundamentals	income_statements_annual	6 rows · 2020 to 2025
Reported vs consensus	fact/earnings_calendar	24 rows · 2020-10-27 to 2026-07-30
Analyst estimates	dim/forward_estimates	3 rows · 2026-12-31 to 2028-12-31
Institutional ownership (13F)	holdings_db.institutional_ownership_summary	38 rows · 2016 to 2026
Insider transactions (Form 4)	edgar/form4	12 rows · 2026-07-02 to 2026-09-01
Proposed sales (Form 144)	edgar/form144	1 record
Beneficial ownership (13D/G)	edgar/13dg	3 rows · 2025-04-24 to 2026-04-28
Short-sale volume (FINRA)	edgar/short_volume_daily	60 rows · 2026-07-23 to 2026-10-15
Dark pool (ATS, tier 1)	edgar/darkpool_weekly	12 rows · 2026-06-15 to 2026-08-31
ETF & fund holding	etf_holdings_changelog (30d)	1 record
Peer set	stock_peers_dynamic	8 rows
Industry medians	industry_medians	1 record
Congressional trades	congress_db (House + Senate)	1 record
ESG	fact/esg_disclosures	1 record

Method. Every figure in this factsheet is looked up from a named field computed in code. It contains no model-written text.

Not covered. Short interest as a percent of float and days-to-cover are not in this data set — the short-sale figures above are FINRA volume, a flow, and cannot support squeeze or covering analysis. Options positioning and intraday data are also absent. 13F ownership is filed 45 days after quarter end and congressional trades are disclosed on a lag, so both describe a past position, not a current one.

Labcorp Holdings Inc. (LH)

Score Breakdown

Peer Comparison — IS Score

IS Score Trend — quarterly

Labcorp Holdings Inc. (LH)

Labcorp Holdings Inc. (LH)

Institutions holding — 12 quarters

Labcorp Holdings Inc. (LH)

Monthly Net Insider Flow (000 shares)

Signal Summary

Labcorp Holdings Inc. (LH)

2.8 · Largest Reporting 13F Managers

2.9 · Top ETF & Fund Ownership

13F Filers Holding LH — quarterly

Institutional Put/Call — quarterly

Where LH Trades in the Dark

Labcorp Holdings Inc. (LH)

3.8 · Employees (SEC filings)

Labcorp Holdings Inc. (LH)

Labcorp Holdings Inc. (LH)

Labcorp Holdings Inc. (LH)

Balance Sheet — Full

Cash Flow Statement — Full

Labcorp Holdings Inc. (LH)

Labcorp Holdings Inc. (LH)

Labcorp Holdings Inc. (LH)

Labcorp Holdings Inc. (LH)

Street Price Target — Trajectory

Third-Party Composite Rating

Labcorp Holdings Inc. (LH)

Labcorp Holdings Inc. (LH)

Family Scores (site weights)

Labcorp Holdings Inc. (LH)

Labcorp Holdings Inc. (LH)

Labcorp Holdings Inc. (LH)